| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 07/11/2006 | US7074776 Exposing bacterium to heterocyclic comound for controlling growth |
| 07/11/2006 | CA2344255C Novel derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane, process for preparing them and pharmaceutical compositions containing them |
| 07/11/2006 | CA2274074C Novel compounds with analgesic effect |
| 07/11/2006 | CA2244870C N,n-disubstituted amic acid derivatives |
| 07/11/2006 | CA2125830C Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis |
| 07/06/2006 | WO2006071868A2 Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof |
| 07/06/2006 | WO2006071047A1 Benzothiophen-2-carbonylguanidine derivatives, preparation thereof, and pharmaceutical composition containing the same |
| 07/06/2006 | WO2006070878A1 Carboxylic acid derivative or salt thereof |
| 07/06/2006 | WO2006070106A1 N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid cb1 receptor antagonists |
| 07/06/2006 | WO2006017215A3 Histone deacetylase inhibitors |
| 07/06/2006 | US20060149083 3,4-Ethylenedioxythiophene obtained by heating using a copper catalyst with very high selectivity in the absence of a solvent by heterogeneous reaction ofthe solid alone; high vapor pressure of product enables discharging in gaseous form together with an inert gas stream; minimun use of auxillaries |
| 07/06/2006 | US20060148887 Chemical compounds |
| 07/06/2006 | US20060148886 Methylthiophene carboxanilides |
| 07/06/2006 | US20060148862 Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 07/06/2006 | DE112004001675T5 Dendrimerverbindung und diese verwendendes organisches lumineszierendes Element Dendrimerverbindung and this-use organic luminescent element |
| 07/06/2006 | DE10248876B4 Verfahren zur Herstellung linearer organischer Oligomere A process for preparing linear organic oligomers |
| 07/06/2006 | DE102004061746A1 Alkinyl-substituierte Thiophene Alkynyl-substituted thiophenes |
| 07/06/2006 | CA2592514A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 07/06/2006 | CA2590681A1 N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid cb1 receptor antagonists |
| 07/05/2006 | EP1676834A1 Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation |
| 07/05/2006 | EP1675844A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 07/05/2006 | EP1675824A1 Somatostatin receptor 1 and/or 4 selective agonists and antagonists |
| 07/05/2006 | EP1385505B1 Acne treatment with lipooxigenase inhibitors |
| 07/05/2006 | EP1113797A4 Treatment of persistent pain |
| 07/05/2006 | CN1798742A Novel biaromatic compounds which activate ppar [upsilon] pharmaceutical compsns |
| 07/05/2006 | CN1798739A 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
| 07/05/2006 | CN1798730A Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use |
| 07/05/2006 | CN1798729A Benzamide nitrile derivatives |
| 07/05/2006 | CN1796351A Method for preparing desmosdumotin, and application of anti tumour and AIDS |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/04/2006 | US7071358 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 07/04/2006 | US7071355 Enzyme inhibitors; anticancer agents; autoimmune diseases; antiprotozoa agents; viricides |
| 07/04/2006 | US7071338 Process for the synthesis of bis-aryl diamidoxime compounds |
| 07/04/2006 | US7071220 Chymase inhibitor; cardiovascular disorders, circulation diseases; hypotensive agents |
| 07/04/2006 | US7071219 For therapy of diseases mediated by the inhibition of histone deacetylase, such as cancer |
| 07/04/2006 | US7071215 Anthelmintic and insecticidal compositions |
| 07/04/2006 | US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 07/04/2006 | US7071195 Especially amino- or amido-ethyltetralin derivatives |
| 07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
| 07/04/2006 | US7071177 P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents |
| 07/04/2006 | CA2250840C Antivirally active heterocyclic azahexane derivatives |
| 07/04/2006 | CA2130797C 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity, and synthesis of .alpha.-substituted-arylacetamides |
| 06/29/2006 | WO2006068162A1 Therapeutic agent for chronic obstructive pulmonary disease |
| 06/29/2006 | WO2006067472A1 Parp inhibitors |
| 06/29/2006 | WO2006067414A2 Glycine transport inhibitors |
| 06/29/2006 | WO2006066879A2 Compounds with kv4 ion channel activity |
| 06/29/2006 | WO2006053791A3 Compounds that modulate ppary type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/29/2006 | US20060142596 Process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates |
| 06/29/2006 | US20060142594 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 06/29/2006 | US20060142567 Process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates |
| 06/29/2006 | US20060142388 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative |
| 06/29/2006 | US20060142347 Compounds and methods for the treatment or prevention of Flavivirus infections |
| 06/29/2006 | US20060142296 4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 06/29/2006 | US20060142271 Novel lapacho compounds and methods of use thereof |
| 06/29/2006 | US20060142267 [6-hydroxy-2-(2-hydroxy-benzyl)-benzo [b]thiophen-3-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; [6-hydroxy-2-(2-hydroxy-benzyl)-naphthalen-1-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; 6-(2-hydroxy-benzyl)-5-{hydroxy-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methyl}-naphthalen-2-ol |
| 06/29/2006 | US20060142252 Tubulin binding agents and corresponding prodrug constructs |
| 06/29/2006 | US20060141383 Sulfonium salts, radiation- sensitive acid generators, and positive radiator-sensitive resin compositions |
| 06/29/2006 | CA2587664A1 Compounds with kv4 ion channel activity |
| 06/28/2006 | EP1674096A2 Hypoglycemics comprising organic zinc (II) complexes |
| 06/28/2006 | EP1673356A1 Substituted benzylaminoalkylene heterocycles |
| 06/28/2006 | EP1673342A2 Amides that inhibit vanilloid receprot subtype 1 (vr1) receptor |
| 06/28/2006 | EP1673090A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 06/28/2006 | EP1673084A1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms |
| 06/28/2006 | EP1673078A2 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/28/2006 | EP1673075A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 06/28/2006 | EP1673059A2 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 06/28/2006 | EP1556377B1 Cyclopropyl-thienyl-carboxamide as fungicides |
| 06/28/2006 | CN1795190A Compounds and methods for the treatment or prevention of flavivirus infections |
| 06/28/2006 | CN1795175A Acetylene derivatives as inhibitors of histone deacetylase |
| 06/28/2006 | CN1261429C Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067538 monocyte chemoattractant protein-1; a bis(phenyl) sulfonyl or sulfonamido ketone or dihydroxy compound; antiinflammatory, anticholesterol, antiarthritic agents; immunotherapy; transplant rejection |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067510 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss |
| 06/27/2006 | US7067119 Using polypeptides |
| 06/27/2006 | CA2238633C Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/22/2006 | WO2006066172A1 Aminopyrimidine compounds and methods of use |
| 06/22/2006 | WO2006065706A1 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 06/22/2006 | WO2006065600A2 N-biaryl and n-arylheteroaryl piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 06/22/2006 | WO2006064957A1 Amide compound and thrombopoietin receptor activator |
| 06/22/2006 | WO2006063657A2 End-stop damper |
| 06/22/2006 | US20060135770 PARP inhibitors |
| 06/22/2006 | US20060135597 Administering a bithiophene substituted by a carboxyalkyl group and a pyridinyl or pyrimidinyl group to treat irritable bowel syndrome, chronic heart failure, angina, cardiac infarction, cerebral infarction, pollakiuria, urinary incontinence, or, cerebral ischemia |
| 06/22/2006 | US20060135572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis |
| 06/22/2006 | US20060135568 Methods of treating microbial infections in humans and animals |
| 06/22/2006 | US20060135515 Heterocyclic amides and their use treating thromboembolic diseases and tumors |
| 06/22/2006 | US20060131762 Method for metal-organic production of organic intermediate products by means of aryl lithium-bases |
| 06/22/2006 | CA2588595A1 N-biaryl and n-arylheteroaryl piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 06/22/2006 | CA2588567A1 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 06/21/2006 | EP1671973A2 Allosteric adenosine receptor modulators |
| 06/21/2006 | EP1670804A2 Heterobicyclic compounds as pharmaceutically active agents |
| 06/21/2006 | EP1670791A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 06/21/2006 | EP1670779A2 Methods for the production of 3-methylamino-1-(thiene-2-yl)-propane-1-ol |
| 06/21/2006 | EP1670755A2 Pyrovalerone analogs and therapeutic uses thereof |
| 06/21/2006 | EP1670749A1 2-substituted benzoic acid derivatives as hm74a receptor agonists |
| 06/21/2006 | EP1670739A2 Cyclic diamines and derivatives as factor xa inhibitors |
| 06/21/2006 | EP1341779B1 Heterocyclic sulfonamide inhibitors of beta amyloid production |